AU Patent

AU2011336413B2 — Liquid viral formulations

Assigned to Oncolytics Biotech Inc · Expires 2015-01-22 · 11y expired

What this patent protects

Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients …

USPTO Abstract

Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients and a liquid carrier. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011336413B2
Jurisdiction
AU
Classification
—
Expires
2015-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Oncolytics Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.